Development and validation of a tool for advising primiparous women during early labour (GebStart-Study)

Organizational Data

DRKS-ID:
DRKS00025572
Recruitment Status:
Recruiting complete, study continuing
Date of registration in DRKS:
2021-07-28
Last update in DRKS:
2024-01-08
Registration type:
Prospective

Acronym/abbreviation of the study

GebStart-Study

URL of the study

https://www.zhaw.ch/de/gesundheit/forschung/hebammen/projekte/entwicklung-und-validierung-eines-tools-fuer-die-beratung-von-erstgebaerenden-in-der-latenzphase-gebstart-studie/

Brief summary in lay language

BACKGROUND: Women giving birth to their first child often struggle to cope with the contractions and discomfort of the latent phase, meaning the symptoms of onset of labour for childbirth. If hospital admission occurs before the birth progresses, this is associated with increased rates of interventions and caesarean sections. However, staying at home in labour can cause anxiety. Care in the latent phase is often unsatisfactory for the woman giving birth and a challenge for health professionals. CONTENT AND AIM OF THE RESEARCH PROJECT: There is an urgent need to develop an instrument that allows for an evidence-based and individual assessment of the physical and emotional state of women in the latent phase. This instrument can be used to determine the care needs of women and advise the decision for or against hospital admission. Therefore, this study will develop and validate a standardised questionnaire for advising primiparous women in the latent phase. In addition to the quality criteria of the questionnaire, the satisfaction of women, midwives and doctors with the use of the instrument will be investigated. The data collection will be carried out in cooperation with six Swiss hospitals. SCIENTIFIC AND SOCIAL CONTEXT OF THE RESEARCH PROJECT: The standardised questionnaire can be used by health professionals during the initial telephone or face-to-face contact with first-time mothers. The structured advising has the potential to shorten hospital stays, increase spontaneous birth rates and reduce intervention rates. The study also aims to make an important contribution to the scientific discussion for optimising care in the latent phase and to provide a basis for further research.

Brief summary in scientific language

BACKGROUND: Pregnant women experience early labour as the first phase of labour with different physical and emotional symptoms. Early admission to hospital has been found to be associated with increased intervention and caesarean section rates. However, primiparous women often contact the hospital before labour progresses because they might have difficulties coping with labour pain at home. Previous studies investigating early labour care have not resulted in increased spontaneous birth rates and have not provided evidence regarding the appropriate care during early labour. An evidence-based instrument assessing the physical and emotional state within the early labour process and the wellbeing of woman and thereby, their need for support, is required to inform the decision for or against hospital admission. OBJECTIVES: The study aims to develop and validate a tool for the structured advice for primiparous women during early labour. The specific objectives are: (a) The evidence-based development of the tool, (b) The assessment of validity (content and construct validity) and reliability (internal consistency) of this instrument, (c) The evaluation of women’s, midwives’ and doctors’ satisfaction with the use of the tool, and (d) The investigation of the potential of the use of the tool to improve perinatal outcomes. METHODOLOGICAL APPROACH: The study will last three years and contains the following steps: (1) Generation of an item pool with 99 items based on a scoping review (symptoms of onset of labour, care and support needs) and focus group discussions with women (experiences) as well as determination of formats of measurements, (2) Assessment of content and face validity by an expert panel and item reduction to 32 items, (3) Multicentre data collection in six sites in the Zurich region as well as Central and Northwest Switzerland, with the application of the preliminary instrument and the validation items with a target sample size of n=400 women, and (4) Exploratory factor analysis for item reduction, designing the final version of the instrument with 15-20 items and assessing quality criteria of the instrument, satisfaction with the use of the instrument and perinatal outcomes. RELEVANCE OF THE PROJECT: The development and validation of a tool to assess the physical and emotional state and wellbeing and thereby, the need of support will provide an instrument to advise primiparous women during early labour. It can be applied by midwives and doctors for the initial telephone or face to face contact. The use of the instrument is of great interest because it has the potential to shorten hospital stays, increase spontaneous birth rates and decrease intervention rates and thereby, lower costs. Additionally, this study will make an important contribution to the scientific discussion for optimising early labour care and provide a basis for further research.

Health condition or problem studied

ICD10:
O80 - Single spontaneous delivery
Healthy volunteers:
Yes

Interventions, Observational Groups

Arm 1:
Application of the preliminary tool (standardised questionnaire) at the first contact with primiparous women during early labour for childbirth. The midwife or the obstetrician will ask standardised questions during the telephone or face-to-face contact with the parturient. The assessment will lead to a score, which will advise the decision “Admitted versus not admitted to hospital”. For the validation of certain items of the newly developed tool, they will be compared with items of the German versions of the Cambridge Worry Scale and the Childbirth Self-Efficacy Inventory.

Endpoints

Primary outcome:
The primary outcome of the study are the validity and the reliability of the tool (standardised questionnaire).
Secondary outcome:
Secondary outcomes are: 1) Mothers: perinatal outcomes such as mode of birth, interventions during childbirth, perineal injuries, breastfeeding, hospital stay, postnatal quality of life, satisfaction with the application of the tool, satisfaction with the care received, 2) Infants: Birth weight, Apgar-Score, umbilical cord pH, admission to NICU, 3) Health professionals: satisfaction with the application of the tool.

Study Design

Purpose:
Prevention
Allocation:
N/A (single arm study)
Control:
  • Uncontrolled/single arm
Phase:
N/A
Study type:
Interventional
Mechanism of allocation concealment:
No Entry
Blinding:
No
Assignment:
Single (group)
Sequence generation:
No Entry
Who is blinded:
No Entry

Recruitment

Recruitment Status:
Recruiting complete, study continuing
Reason if recruiting stopped or withdrawn:
No Entry

Recruitment Locations

Recruitment countries:
  • Switzerland
Number of study centers:
Multicenter study
Recruitment location(s):
  • Medical center University Hospital of Basel, University Hospital of Zurich, Cantonal Hospital of Baden, Cantonal Hospital of Lucerne, Cantonal Hospital of Winterthur, City Hospital Triemli in Zurich Baden, Basel, Luzern, Zürich, Winterthur

Recruitment period and number of participants

Planned study start date:
2022-03-01
Actual study start date:
2022-03-01
Planned study completion date:
2024-04-30
Actual Study Completion Date:
No Entry
Target Sample Size:
550
Final Sample Size:
627

Inclusion Criteria

Sex:
Female
Minimum Age:
18 Years
Maximum Age:
no maximum age
Additional Inclusion Criteria:
• Pregnant women ≥ 18 years old • Sufficient oral and written German language knowledge • Expecting the first child • Singleton • Cephalic presentation • No elective caesarean section planned • No labour induction planned

Exclusion Criteria

• Pregnant women expecting their second child or more • Multiple pregnancy • Elective caesarean section or labour induction planned

Addresses

Primary Sponsor

Address:
Zürcher Hochschule für Angewandte Wissenschaften, Departement Gesundheit, Institut für Hebammenenwissenschaft und reproduktive Gesundheit
Prof. Dr. Susanne Grylka-Baeschlin
Katharina-Sulzer-Platz 9
CH-8401 Winterthur
Switzerland
Telephone:
+41 58 934 43 77
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.zhaw.ch/de/gesundheit/
Investigator Sponsored/Initiated Trial (IST/IIT):
Yes

Contact for Scientific Queries

Address:
Zürcher Hochschule für Angewandte Wissenschaften, Departement Gesundheit, Institut für Hebammenwissenschaft und reproduktive Gesundheit
Prof. Dr. Susanne Grylka-Baeschlin
Katharina-Sulzer-Platz 9
CH 8401 Winterthur
Switzerland
Telephone:
+41 58 934 43 77
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.zhaw.ch/de/gesundheit/

Contact for Public Queries

Address:
Zürcher Hochschule für Angewandte Wissenschaften, Departement Gesundheit, Institut für Hebammenwissenschaft und reproduktive Gesundheit
Prof. Dr. Susanne Grylka-Baeschlin
Katharina-Sulzer-Platz 9
CH-8401 Winterthur
Switzerland
Telephone:
+41 58 934 43 77
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.zhaw.ch/de/gesundheit/

Principal Investigator

Address:
Zürcher Hochschule für Angewandte Wissenschaften, Departement Gesundheit, Institut für Hebammenwissenschaft und reproduktive Gesundheit
Prof. Dr. Susanne Grylka-Baeschlin
Katharina-Sulzer-Platz 9
CH 8401 Winterthur
Switzerland
Telephone:
+41 58 934 43 77
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.zhaw.ch/de/gesundheit/

Sources of Monetary or Material Support

Public funding institutions financed by tax money/Government funding body (German Research Foundation (DFG), Federal Ministry of Education and Research (BMBF), etc.)

Address:
Schweizerischer Nationalfonds
Wildhainweg 3
CH-3001 Bern
Switzerland
Telephone:
41 31 308 22 22
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.snf.ch/de

Ethics Committee

Address Ethics Committee

Address:
Kantonale Ethikkommission Zürich [Ethics Commitee Zurich]
Stampfenbachstrasse 121
CH-8090 Zürich
Switzerland
Telephone:
+41 43 259 79 70
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.zh.ch/de/gesundheitsdirektion/ethikkommission.html

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2021-03-23
Ethics committee number:
2021-00687
Vote of the Ethics Committee:
Approved
Date of the vote:
2021-07-27

Further identification numbers

Other primary registry ID:
SNCTP000004555 - Swiss National Clinical Trials Portal
EudraCT Number:
No Entry
Other secondary IDs:
PT00P1_199085 - Swiss National Science Foundation
UTN (Universal Trial Number):
No Entry
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
Yes
IPD Sharing Plan:
Health-related data is considered to be sensitive personal data by the Swiss Federal Act on Data Protection. Thus, procedures have also to comply with the current GCP standards and the Human Research Act of Switzerland. Primary owner of all data collected in this study are the participants that participate herein. In order to use their data for scientific research, approval by the participants and by an ethical committee has to been obtained. Data can only be shared with third parties after this approval. Following the FAIR data principles, FORSbase and DaSCH and maybe further repositories will be evaluated during the project as potential repositories for the publication of approved and anonymised data. Approved and anonymised data will be shared with the final scientific publications related to the respective data.

Study protocol and other study documents

Publication of study results

Basic reporting

Basic Reporting / Results tables:
No Entry
Brief summary of results:
No Entry